Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Inhibition of thrombin and SFLLR-peptide stimulation of platelet aggregation, phospholipase A2 and Na+/H+ exchange by a thrombin receptor antagonist.

Seiler SM, Peluso M, Michel IM, Goldenberg H, Fenton JW 2nd, Riexinger D, Natarajan S.

Biochem Pharmacol. 1995 Feb 14;49(4):519-28.

PMID:
7872957
2.

Comparison of thrombin active site and exosite inhibitors and heparin in experimental models of arterial and venous thrombosis and bleeding.

Schumacher WA, Steinbacher TE, Heran CL, Seiler SM, Michel IM, Ogletree ML.

J Pharmacol Exp Ther. 1993 Dec;267(3):1237-42.

PMID:
8263785
3.

Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.

Harris DN, Michel IM, Goldenberg HJ, Hartl KS, Allen GT, Steinbacher TE, Schumacher WA, Han WC, Hall SE, Floyd DM, et al.

J Pharmacol Exp Ther. 1992 Apr;261(1):131-7.

PMID:
1532833
4.

Involvement of the "tethered-ligand" receptor in thrombin inhibition of platelet adenylate cyclase.

Seiler SM, Michel IM, Fenton JW 2nd.

Biochem Biophys Res Commun. 1992 Feb 14;182(3):1296-302.

PMID:
1371679
5.

Multiple pathways of thrombin-induced platelet activation differentiated by desensitization and a thrombin exosite inhibitor.

Seiler SM, Goldenberg HJ, Michel IM, Hunt JT, Zavoico GB.

Biochem Biophys Res Commun. 1991 Dec 16;181(2):636-43.

PMID:
1755847
6.

Antithrombotic effects of the thromboxane A2 antagonist, SQ 28,668, in vitro and in the coronary circulation in vivo.

Ogletree ML, Harris DN, Heran CL, Phillips MB, Michel IM, Goldenberg HJ.

Eicosanoids. 1988;1(2):85-91.

PMID:
2856188
7.

Cooperative mediation by serotonin S2 and thromboxane A2/prostaglandin H2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenoses.

Ashton JH, Ogletree ML, Michel IM, Golino P, McNatt JM, Taylor AL, Raheja S, Schmitz J, Buja LM, Campbell WB, et al.

Circulation. 1987 Oct;76(4):952-9.

PMID:
3652429
8.

7-Oxabicycloheptane analogs: modulators of the arachidonate cascade.

Harris DN, Hedberg A, Phillips MB, Michel IM, Goldenberg HJ, Liu EC.

Adv Prostaglandin Thromboxane Leukot Res. 1987;17A:482-6.

PMID:
2959101
9.

Inhibition of prostaglandin biosynthesis by SQ 28,852, a 7-oxabicyclo[2.2.1]heptane analog.

Harris DN, Phillips MB, Michel IM, Goldenberg HJ, Steinbacher TE, Ogletree ML, Hall SE.

Prostaglandins. 1986 Apr;31(4):651-67.

PMID:
3088677
10.

Effects of SQ 27,427, a thromboxane A2 receptor antagonist, in the human platelet and isolated smooth muscle.

Harris DN, Greenberg R, Phillips MB, Michel IM, Goldenberg HJ, Haslanger MF, Steinbacher TE.

Eur J Pharmacol. 1984 Aug 3;103(1-2):9-18.

PMID:
6090180
11.

Some biochemical activities of 10,10-difluoro-13-dehydroprostacyclin, a chemically stable analog of prostacyclin, in human blood platelets.

Harris DN, Phillips MB, Michel IM, Goldenberg HJ, Haslanger MF, Antonaccio MJ, Fried J.

Thromb Res. 1981 Aug 15-Sep 1;23(4-5):387-99. No abstract available.

PMID:
6275567
12.

9 alpha-homo-9,11-epoxy-5,13-prostadienoic acid analogues: specific stable agonist (SQ 26, 538) and antagonist (SQ 26, 536) of the human platelet thromboxane receptor.

Harris DN, Phillips MB, Michel IM, Goldenberg HJ, Heikes JE, Sprague PW, Antonaccio MJ.

Prostaglandins. 1981 Aug;22(2):295-307.

PMID:
6270744
13.

Synthesis and central nervous system activity of 2-arylidene-4-aminoalkyl-2H-1,4-benzoxazin-3(4H)-ones and related compounds.

Turk CF, Krapcho J, Michel IM, Weinryb I.

J Med Chem. 1977 May;20(5):729-32. No abstract available.

PMID:
853510
15.

Cyclic nucleotides vs. adenosine analogs as inhibitors of adenylate cyclase activity: nonidentity of sites of action.

Weinryb I, Michel IM.

Experientia. 1975 Aug 15;31(8):892-4. No abstract available.

PMID:
169141
16.
17.

Interactions of alpha-methylfluorene-2-acetic acid with adenylate cyclase.

Weinryb I, Michel IM.

Biochem Pharmacol. 1974 Sep 1;23(17):2411-9. No abstract available.

PMID:
4154750
18.

Adenylate cyclase from guinea pig lung: further characterization and inhibitory effects of substrate analogs and cyclic nucleotides.

Weinryb I, Michel IM, Hess SM.

Arch Biochem Biophys. 1973 Jan;154(1):240-9. No abstract available.

PMID:
4347680
19.

Effects of therapeutic agents on cyclic AMP metabolism in vitro.

Weinryb I, Chasin M, Free CA, Harris DN, Goldenberg H, Michel IM, Paik VS, Phillips M, Samaniego S, Hess SM.

J Pharm Sci. 1972 Oct;61(10):1556-67. No abstract available.

PMID:
4342043
20.

Radioimmunoassay of cyclic AMP without precipitating antibody.

Weinryb I, Michel IM, Hess SM.

Anal Biochem. 1972 Feb;45(2):659-63. No abstract available.

PMID:
4334220
21.

Divergent effects of theophylline on adenylate cyclase preparations from guinea-pig heart and lung.

Weinryb I, Michel IM.

Experientia. 1971 Dec 15;27(12):1386. No abstract available.

PMID:
4335707
22.

Effects of barbiturate derivatives, sulfhydryl reagents, and oxidizing agents on the activity of adenylate cyclase from guinea pig heart and lung.

Weinryb I, Michel IM, Alicino JF, Hess SM.

Arch Biochem Biophys. 1971 Oct;146(2):591-6. No abstract available.

PMID:
5114922

Supplemental Content

Loading ...
Support Center